ExploreInsights

Mike Gallatin

Advisor

Mike brings over 35 years of experience as a scientist and executive to the OncoResponse Scientific Advisory Board. He is a member of Frazier Healthcare Partners' Life Sciences team, has co-founded Calistoga (acquired by Gilead) and Stromedix (acquired by Biogen Idec) and served as President of Calistoga, which was the first company to demonstra...

Roles at OncoResponse

  • Advisor

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.